|
GRIPAP1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.682000E-03 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.039200E-03 |
| Normal-vs-Stage2 |
2.553800E-02 |
| Normal-vs-Stage3 |
8.553900E-02 |
| Normal-vs-Stage4 |
2.818300E-02 |
| Stage1-vs-Stage2 |
5.570800E-01 |
| Stage1-vs-Stage3 |
3.669200E-01 |
| Stage1-vs-Stage4 |
9.447400E-01 |
| Stage2-vs-Stage3 |
2.532400E-01 |
| Stage2-vs-Stage4 |
6.759400E-01 |
| Stage3-vs-Stage4 |
4.647000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.244400E-03 |
| Normal-vs-AfricanAmerican |
5.89989999999485E-05 |
| Normal-vs-Asian |
3.402900E-03 |
| Caucasian-vs-AfricanAmerican |
1.912380E-02 |
| Caucasian-vs-Asian |
4.183400E-01 |
| AfricanAmerican-vs-Asian |
9.148400E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.020400E-03 |
| Normal-vs-Female |
5.243700E-03 |
| Male-vs-Female |
6.595400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.623700E-03 |
| Normal-vs-Age(41-60Yrs) |
7.995700E-03 |
| Normal-vs-Age(61-80Yrs) |
1.090360E-01 |
| Normal-vs-Age(81-100Yrs) |
7.687700E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.259800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.014200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.162400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.384800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.519000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.547600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.222470E-03 |
| Classical-VS-Follicular |
1.599240E-03 |
| Classical-VS-Other |
5.361900E-02 |
| Classical-VS-Normal |
1.95530999999027E-05 |
| Tall-VS-Follicular |
6.246400E-01 |
| Tall-VS-Other |
8.080600E-01 |
| Tall-VS-Normal |
7.610800E-01 |
| Follicular-VS-Other |
6.859000E-01 |
| Follicular-VS-Normal |
7.784400E-01 |
| Other-VS-Normal |
6.239800E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.717200E-03 |
| Normal-vs-N1 |
3.546400E-01 |
| N0-vs-N1 |
3.082200E-01 |
|
|
